Abstract
Malignant pleural effusion (MPE) is a common complication of lung cancer with devastating consequences. Since vascular endothelial growth factor (VEGF) has been implicated in MPE, we hypothesized that bevacizumab, an anti-VEGF antibody, may be effective against MPE in patients with non-small-cell lung cancer (NSCLC). We analysed the records of 21 patients treated for NSCLC-associated MPE between February, 2010 and August, 2013 who consequently underwent bevacizumab combination chemotherapy at the Institute of Biomedical Research and Innovation Hospital. The results were retrospectively analysed using case records and radiographic imaging records. Three patients exhibited complete response of the pleural effusion to bevacizumab treatment, 8 patients achieved a partial response (PR) and 6 patients showed no response. When efficacy was assessed by the response of the measurable primary or metastatic lesions to the treatment, 5 patients achieved a PR, 13 patients had stable disease and 3 patients exhibited progressive disease. The response rate (RR) of the pleural effusion to the antibody treatment was 71.4% and the overall RR of measurable lesions was 23.8%. The median time-to-response for pleural effusion was 132 days. In conclus...Continue Reading
References
Apr 1, 1974·Cancer·C B AndersonT B Ferguson
Feb 1, 1981·Current Problems in Cancer·A Memon, Z A Zawadzki
Oct 20, 1998·The American Journal of Pathology·S MesianoR B Jaffe
Sep 24, 1999·Chest·D ChengR W Light
Sep 29, 1999·Cancer Immunology, Immunotherapy : CII·H YanagawaS Sone
Feb 3, 2000·Journal of the National Cancer Institute·P TherasseS G Gwyther
May 10, 2000·The Oncologist·H M VerheulH M Pinedo
Dec 7, 2000·The American Journal of Pathology·S YanoI J Fidler
Feb 15, 2001·Chest·A FujitaK Sekine
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H JohnsonFairooz Kabbinavar
May 12, 2005·Angiogenesis·Yaning WangAn Song
Aug 19, 2005·The New England Journal of Medicine·Oskar PichelmayerMarkus Raderer
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN Participating Institutions
Jan 23, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·I-Lin HsuWu-Wei Lai
May 14, 2009·Current Opinion in Pulmonary Medicine·Ali I Musani
Oct 13, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Sabrina C C RibeiroLisete R Teixeira
Oct 5, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Erin M Bertino, Gregory A Otterson
Nov 28, 2012·Cancer Chemotherapy and Pharmacology·Kazuhiro KitamuraAkihiko Gemma
Jan 4, 2013·PloS One·Xingqun MaYong Song
Mar 26, 2013·Oncology Reports·Nan DuHuanrong Kang
Sep 3, 2013·Clinics in Chest Medicine·Justin M Thomas, Ali I Musani
Citations
Sep 25, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jiyoul YangHye Sook Han
Feb 15, 2019·Thoracic Cancer·Ryota ShibakiYuichiro Ohe
Feb 10, 2019·The Clinical Respiratory Journal·Claire TissotMarios E Froudarakis
Jul 29, 2018·The European Respiratory Journal·Anna C BibbyNick A Maskell
Dec 6, 2018·Reviews on Recent Clinical Trials·Fausto Meriggi
Dec 19, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·D Marquez-Medina, S Popat
Nov 15, 2019·Thoracic Cancer·Keke NieYouxin Ji
Jan 27, 2018·Oncotarget·Sun ZongwenZhang Yan
Oct 6, 2017·Oncotarget·Tao JiangJun Zhang
Mar 9, 2017·Expert Review of Respiratory Medicine·José M PorcelY C Gary Lee
Jul 31, 2018·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Anna C BibbyGiuseppe Cardillo
Jan 4, 2018·Thoracic Cancer·Hong TaoZhe Liu
Jul 25, 2020·Cancer Science·Chih-Ying ChangchienChen-Liang Tsai
Dec 14, 2017·Expert Review of Respiratory Medicine·Ralph Llewel SabangOleg Epelbaum
Apr 26, 2018·Molecular Medicine Reports·Yao ChenHongda Lu
Mar 25, 2019·Oncoimmunology·Pranav MurthyMichael T Lotze
Dec 5, 2018·Biosensors & Bioelectronics·Xuanying LiZhenzhong Guo